A gene shared by salamanders, zebrafish and mice could point toward a new path for regenerative medicine: researchers have identified key genetic programs involved in regrowth and used them to partially restore digit regeneration in mice. The findings do not bring human limb regeneration within immediate reach, but they offer a promising proof of principle for future gene-based therapies.
A Mexican axolotl in Wake Forest University biologist Josh Currie's regeneration lab.
(Source: Wake Forest University/ Lyndsie Schlink)
Investigating a common gene in three very different species — axolotls, mice and zebrafish — scientists have discovered the potential for a novel gene therapy aimed at eventually regrowing limbs in humans, according to new research published this week.
“This significant research brought together three labs, working across three organisms to compare regeneration,” said Wake Forest Assistant Professor of Biology Josh Currie, whose lab studies the Mexican axolotl salamander. “It showed us that there are universal, unifying genetic programs that are driving regeneration in very different types of organisms, salamanders, zebrafish and mice.”
The research, with results appearing in the Proceedings of the National Academy of Sciences, included David A. Brown, a plastic surgeon who studies digit regeneration in mice at Duke University, and Kenneth D. Poss, who studies fin regeneration in zebrafish at the University of Wisconsin-Madison.
Each year, around the world, more than 1 million limb amputations occur because of vascular diseases such as diabetes, traumatic injuries, cancer or infections, according to annual Global Burden of Disease statistics. The number is expected to rise with the aging population and the increase in diabetes diagnoses.
That looming challenge has inspired Brown, Currie and Poss to search for a treatment beyond prosthetics, for something that could replace the complex senses and motor skills of an actual limb.
They might have found the start of a solution in something called SP genes, which the scientists discovered are vital for limb regeneration and shared by the mouse, zebrafish and axolotl.
Therapy Makes up for Missing Gene
The scientists chose to study these three animals for specific reasons:
The axolotl excels at regeneration, with the ability to regrow complete limbs; tails, including the spinal cord; parts of the heart, brain, liver, lungs and jaw.
Zebrafish offer one of the best models for appendage regeneration because their tail fins regrow rapidly and have unlimited capacity for regrowth. The zebrafish also can regenerate its heart, spinal cord, brain, retinas, kidneys and pancreas.
Mice represent mammals like humans, and they already can regenerate the tips of their digits. Humans, too, can regrow their fingertips when an injury preserves the nailbed. That allows regrowth of flesh, skin and bone.
Currie said that once the scientists determined the regenerating epidermis, or skin, of all three species expressed the SP genes SP6 and SP8, they set out to test what the genes do and how they work.
Biology Ph.D. student Tim Curtis Jr. contributed to the research in the Currie lab, with assistance from undergraduate Elena Singer-Freeman, a Goldwater Scholar and 2025 Wake Forest biochemistry and molecular biology graduate.
Emulating the Abilities of Salamander Genes
In salamanders, SP8 does the work in regenerating limbs. Using CRISPR gene-editing technology, Currie’s lab removed SP8 from the axolotl genome. Without SP8, the axolotl could not properly regenerate the limb bones; a similar result occurred with the mouse digits missing SP6 and SP8.
With that information in hand, Brown’s lab used a tissue regeneration enhancer found in zebrafish to develop a viral gene therapy.
That therapy delivered a secreted molecule called FGF8, a gene that is usually turned on by SP8, to encourage digit bone regrowth and partially restore the regenerative effects of the missing SP genes in mice.
Human limbs don’t have that kind of regenerative power — but might someday, with a therapy that emulates the abilities of SP genes.
“We can use this as a kind of proof of principle that we might be able to deliver therapies to substitute for this regenerative style of epidermis in regrowing tissue in humans,” Currie explained.
Although it will require much more research to take the findings from mouse digits to human limbs, Currie called this study foundational in the search for therapies to regrow limbs after injury or disease.
“Scientists are pursuing many solutions for replacing limbs, including bioengineered scaffolds and stem cell therapies,” Currie explained. “The gene-therapy approach in this study is a new avenue that can complement and potentially augment what will surely be a multi-disciplinary solution to one day regenerate human limbs.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
He said the decision to collaborate among scientists studying such different animals made all the difference in this research.
“Many times, scientists work in their silos: we're just working in axolotl, or we're just working in mouse, or just working in fish,” Currie said. “A real standout feature of this research is that we work across all these different organisms. That is really powerful, and it's something that I hope we'll see more of in the field.”
Original Article: Enhancer-directed gene delivery for digit regeneration based on conserved epidermal factors; Proceedings of the National Academy of Sciences; DOI:10.1073/pnas.2532804123